Antihypertensive Property of Celery: A Narrative Review on Current Knowledge

Alobaidi, Sondos; Saleh, Eman

doi:https://doi.org/10.1155/2024/9792556

International Journal of Food Science

On this page

Abstract Introduction Methods Results Discussion Conclusion Data Availability Conflicts of Interest References Copyright Related Articles

Review Article | Open Access

Volume 2024 | Article ID 9792556 | https://doi.org/10.1155/2024/9792556

Antihypertensive Property of Celery: A Narrative Review on Current Knowledge

Sondos Alobaidi¹and Eman Saleh²

Academic Editor: Simone Carradori

Received17 Jan 2024

Revised17 Feb 2024

Accepted26 Feb 2024

Published12 Mar 2024

Abstract

Background. The incidence of hypertension is increasing significantly on a global scale, and it is considered the leading cause of heart disease and death. Despite the availability of hypotensive drugs, they have many side effects that decrease adherence to treatments and lead to uncontrolled blood pressure. Studies have revealed that celery contains bioactive compounds that oppose hypotensive effect. Methods. A thorough literature review was conducted using Scopus, PubMed, and Google Scholar databases. To identify relevant studies on the topic, our search strategy employed keywords such as “celery,” “Apium gravenols L,” “hypertension,” “high blood pressure,” “apigenin,” “antihypertensive,” and “hypotensive.” The search was limited to articles published between January 2013 and December 2023. The inclusion criteria were original research articles that involved both animal and human subjects, published in English, and reported results applicable to the subject of this review. Review articles or articles in the form of theses or books were excluded. Results. The available evidence revealed that celery enhances blood pressure parameters. Clinical trials clarified that celery possesses its effect through many bioactive compounds, specifically 3-n-butylphthalide and apigenin. Based on animal and human studies, celery seems to elicit blood pressure regulation mainly by the vasodilatory, diuretic, and calcium channel-blocking properties. Furthermore, celery seed extract seems to exert a bradycardia effect. Conclusion. The current literature review showed a considerable number of studies on the hypertensive models, which confirmed that celery and its extracts are effective hypotensive agents. Some limitations in comparing published data should be considered, including differences in doses, extracts, species of celery, and administration form.

1. Introduction

The incidence of hypertension is increasing significantly on a global scale, and it is considered the main cause of cardiovascular disease (CVD) [1]. While CVD is the primary cause of death globally, it is expected to account for 29% of deaths by 2025. The danger of hypertension lies in its silent symptoms, which cause a variety of complications and morbidities [2]. The World Health Organization (WHO) specifies high blood pressure in measurements equal to and above 140/90 mmHg [3]. Many hypotensive medications control and treat high blood pressure, including diuretics, vasodilators, calcium channel blockers, renin inhibitors, and angiotensin-converting enzyme inhibitors [4]. Despite the availability of these drugs, they have many side effects, such as edema, muscle cramps, skin rashes, vomiting, and kidney failure [3]. Thus, side effects decrease the adherence of hypertensive patients to their treatment, which leads to uncontrolled blood pressure [4]. Populations’ growing acceptance of alternative medicine and herbal plants has increased, especially among developing countries [1]. Approximately 80% of the population accepted this approach to treatment because it is safer and less expensive, has fewer side effects, and is more compatible with human bodies [5].

Celery (Apium graveolens), a biennial herb native to the Mediterranean region, has been cultivated for centuries. For over 200 years, it has been grown for medicinal purposes before being consumed as a food ingredient [6]. Celery is characterized by its exceptional yield and high resistance to disease. Studies have revealed that celery is abundant in vitamins, minerals, phthalides, and flavonoids like apigenin and luteolin, which have strong anti-inflammatory and antitumor properties. Additionally, celery contains silica, chlorophyll, and high fiber content and comprises approximately 95% water [6]. Because of its antioxidant and potential anti-inflammatory properties, different parts (seeds, leaves, stems, and roots) have been used in traditional remedies to treat arthritis, urinary tract diseases, and high blood pressure. Furthermore, it has a protective effect against CVD, high lipid profile, elevated blood sugar readings in type 2 diabetic patients, and obesity [6–8].

The extraction of bioactive compounds from celery can be influenced by the plant part and method used. Unfortunately, the use of phenolic compounds is restricted due to issues with low bioavailability, solubility, stability, and imprecise release [6, 9]. However, recent advancements in nanoencapsulation lipid-based methods are aimed at enhancing the targeted delivery of these functional compounds. Cutting-edge technologies, such as lipid-based nanoparticles, nanocrystals, and solubility-enhancing agents, such as cyclodextrin, have shown promise in improving the effectiveness of celery compounds [1, 10].

Active components of celery, including 3-n-butylphthalide (NBP) and apigenin, can help lower blood pressure by acting as diuretics and vasodilators. Additionally, their effectiveness is similar to that of calcium channel blocker drugs [11, 12]. They can also decrease cholesterol levels and arterial plaque formation, contributing to lower blood pressure. Unlike typical diuretic drugs, NBP and apigenin do not disrupt the balance between sodium and potassium levels in the blood [13]. In traditional Chinese and Indonesian societies, celery has been used to treat and control high blood pressure for a long time with effective results because of its safety and affordability, without side effects [10, 11]. Therefore, the management of hypertension can be achieved pharmaceutically and nonpharmaceutically using herbal plants such as celery [14]. Thus, the purpose of this review is to assess the impact of celery on lowering blood pressure in individuals with hypertension. The review summarized the research, providing information on the study design, sample size, intervention protocol, and efficiency of the celery intervention in reducing blood.

2. Methods and Search Strategy

A thorough literature review was conducted using Scopus, PubMed, and Google Scholar databases. To identify relevant studies on the topic, our search strategy employed keywords such as “celery,” “Apium gravenols L,” “hypertension,” “high blood pressure,” “apigenin,” “antihypertensive,” and “hypotensive.” The search was limited to articles published between January 2013 and December 2023. The inclusion criteria were original research articles that involved both animal and human subjects, published in English, and reported results applicable to the subject of this review. Review articles or articles in the form of theses or books were excluded.

2.1. Data Extraction

Titles and abstracts of 179 studies included in the search were analyzed by two independent reviewers. Subsequently, full-text articles were read to determine whether they qualified for inclusion in the review, and only 12 studies related to the hypotensive effect of celery were extracted. Information about the study design, sample size, celery administration protocols, and outcomes was extracted from eligible studies (Figure 1).

2.2. Data Synthesis

Narrative synthesis was performed to collect and summarize the extracted studies. The results of these studies were classified as animal or human studies. A description of each study’s design, sample size, intervention strategy, and findings is included in the synthesis. For this narrative review, both authors individually gathered information from each manuscript to minimize potential biases and errors. Subsequently, they collectively agreed on the final selection of the studies to be included.

3. Results

3.1. Literature Search

Twelve articles regarding the effectiveness of celery on hypertension were obtained from the database and included in this narrative review. Five articles were on animals and seven were on humans.

3.2. Effect of Celery and Its Extracts on Hypertension

Five experimental studies that used animal models to study the effects of celery on hypertension were included in this review. Of those trials, four studies demonstrated that celery and its different extracts caused a significant decrease in blood pressure in a hypertensive study model [15–18]. However, Tashakori-Sabzevar et al. [15] reported that the hypotension effect of celery was found not only in hypertensive groups but also in normotensive groups [15]. Another study showed that celery extract has a vasorelaxant effect on rat aortic rings, which has a positive impact on BP, but there was no measurement of BP reduction [19].

It is noteworthy that four of the included animal studies were controlled trials. Studies have used different control models such as tap or distilled water [17, 18], hypertension-lowering agents (spironolactone [16] and nifedipine [15]), and induced-hypertension models such as fructose-induced hypertension [17], liquid paraffin and normal saline [16], and NaCl with prednisone [18].

Moghadam et al. [16] and Tashakori-Sabzevar et al. [15] analyzed the n-butylphthalide content using different extraction methods. They found that hexanic celery extract had a higher n-butylphthalide content than methanolic [16] or ethanolic extracts [15, 16].

Regarding the effect of celery on heart rate, studies in this review reported different heart rate responses after celery treatment, ranging from increased heart rate [16], decreased heart rate [15], and no alteration [17].

Rosa and Rivai [18] showed the effect of combining celery with another medicinal plant, garlic. The results demonstrated a significant reduction in the BP. However, this result was heavily influenced by the dose and duration of administration of this combination [18].

Seven interventional trials conducted in humans were included in this review. All of these trials confirmed that celery had a positive effect on hypertension. Statistically, six studies showed a significant reduction in BP after celery administration [9, 12, 20–23]. One trial was a case report of an elderly man with chronic hypertension who experienced uncommon side effects from hypertension medications. Administration of celery juice in his treatment regimen for six months resulted in a positive response and a reduction in SBP by 32 mmHg [13].

All included studies in this review, with the exception of case report one, were controlled trials using either placebo [12, 20–22] or no treatment groups [9, 23] to evaluate the effect of celery.

Administration of 250 mg of celery stem extract reduced 9.59 mmHg in SBP and 15.2 mmHg in DBP [23]. Also, intervention with 1.34 g of celery seed extract showed a reduction of 11 mmHg in SBP and 8 mmHg in DBP [22]. These results confirm the positive effect of celery extract on hypertension.

A BP reduction of 11 mmHg in SBP was shown after administration of ethanolic celery seed extract [12, 20, 22]. A reduction in SBP of 17 mmHg was found after celery juice treatment [9], and a reduction of 19 mmHg was found after ethanolic celery stem extract [23]. This indicates that the extraction method and plant parts influence the effect of celery on the BP.

In terms of the safety of using celery as a supplement, Gautam [20] reported that celery seed extract is safe and well tolerated by patients with hypertension [20]. In addition, Shayani Rad et al.’s [22] study showed that the results of safety parameters demonstrated that celery seed extraction is safe and beneficial in different biochemical parameters [22]. Table 1 summarizes studies on the hypotensive effects of celery.

3.3. Underlying Mechanism of Action of Antihypertension Bioactive Compounds of Celery in Hypertension

Hypertension is a serious health problem and a factor that worsens other cardiovascular diseases. Also, it is a principal cause of premature mortality. Regarding the pathophysiology of hypertension, there are many effectors involved. Potassium channels, renin-angiotensin system, nitric oxide, calcium ions, and reactive oxygen species are the most important effectors that regulate the tone of the vascular system. Therefore, any disruption of one of these effectors may lead to hypertension [24].

Although there are several types of hypertension-lowering pharmaceutical agents, natural sources have inspired many compounds that can modulate the hypertension pathway with minimal side effects. One of the natural plants traditionally used to lower BP is celery or other types of celery extracts (stem, seed, and leaves) [6]. Various plant parts have been used in extraction and medical applications. Celery contains many bioactive compounds that have a positive effect on hypertension reduction [6].

Data from in vitro and in vivo animal studies have demonstrated that celery exerts beneficial effects on hypertension. In rats with hypertension, ethanolic celery seed extracts (0.05, 0.1, 0.25, 0.5, 1, and 2 mg/ml) exerted a vasorelaxant effect on rat aortic rings. The possible mechanisms of action include calcium influx blocking into smooth muscle cells and voltage-dependent potassium channel activation [19]. One of the most bioactive compounds of celery is n-butylphthalide, and it can also exert a beneficial effect on lowering the blood pressure. Hexanic extract of celery contains 3.7-4 more times of n-butylphthalide, and at a dose of 300 mg/kg, the extract can decrease SBP by about 38 mmHg [16]. Also, other bioactive compounds in celery play a role in BP reduction, such as high expression of angiotensin-converting enzyme 2 by apigenin [25], vasodilation by linalool [26], and inhibition of angiotensin II proliferation and migration by luteolin [27].

The complete mechanism of action by which celery and its compounds can regulate blood pressure is not clearly understood in the literature. However, it is now possible to postulate its proposed mechanism(s) of action on blood pressure. Table 2 summarizes the mechanism of action of the possible hypotensive bioactive compounds in celery and different parts of the plants.

4. Discussion

The current narrative review provides the available evidence from animal and human intervention trials evaluating the effect of celery on hypertension in the last decade. Collectively, the results of this literature search showed a considerable number of studies on the topic. The potential effect of celery on hypertension has been extensively discussed. Celery is a medicinal herb, and it has been widely reported to possess an antihypertension property. However, recent scientific data suggest semisimilar results in human and animal studies, with little quantitative difference in responses and BP reduction. The possible reason for the different results may be due to the use of different doses, duration of intervention, and celery species, in addition to different administration forms (whole plant or extract’s capsule). Moreover, some other studies have assessed the influence of celery, and they reported that it could also be affected by the method of extracting and the extracted plant part. It is worthy to note that the effect of celery and its extracts is considered to be dose dependent in addition to the influence of the duration of administration.

In hypertensive patients, the SBP and DBP could be regulated with celery administration. This property of celery is assumed to play an essential role because hypertension is the main factor that worsens other cardiovascular diseases, and it is considered the silent killer [35].

Celery extracts contain different bioactive compounds that aid in BP regulation. Each of these compounds exerts its effect through different pathways. Recent studies have focused on the n-butylphthalide content during extraction [15, 16]. This compound exerts its effect via diuretics and vasodilation and decreases oxidative stress and the expression of IL-6, TNF-α, and NF-κB [16, 28, 29].

Other possible bioactive compounds responsible for the hypotensive effect could be Apium graveolens [31], n-butylphthalide [16, 28, 29], D-limonene [32], apigenin [30], linalool [26], and luteolin [27]. Nevertheless, using the whole plant or part of it also showed a positive effect on BP [1, 15, 17, 34].

Various studies have explored the hypotensive effect of celery, with a focus on its molecular mechanism. Tashakori-Sabzevar et al. [15] demonstrated that one of the possible mechanisms of the hypotension effect is a blocking of calcium influx into cells or calcium release from the sarcoplasmic network that is found in smooth muscles [15]. In addition, the nitric oxide pathway is involved in celery’s vasorelaxant effect. However, disruption of the endothelium could effectively decrease the vasorelaxant effect of celery, indicating that nonendothelial pathways are more likely to be involved in this effect [15]. In contrast, Sohrabi et al. [19] reported an endothelium-dependent pathway in the preventive vasodilation effect of celery. The indication for this finding was the pretreatment of aortic rings with indomethacin or L-NAME, which did not prevent the vasodilation effect of celery, indicating the involvement of other endothelium-dependent pathways in celery vasodilation [19]. In addition, Branković et al. [36] further demonstrated that both aqueous and ethanol extracts of celery can lower blood pressure and reduce the contractility of isolated atria, potentially mediated by muscarinic receptor stimulation [36]. A recent molecular study conducted by Ma et al. [37] revealed that many components in celery seeds play main roles in the ACE inhibitory activity including flavonoids, terpenoids, and carbohydrates. It is worth noting that ultrafiltration technique in this study increases ACE inhibitory activity of celery seed aqueous extract [37].

Further studies should be conducted in order to understand the long-term effects of celery supplementation. Also, identification of the most bioactive compounds in celery exerts the antihypertensive effect and their complete mechanism of action. The dose-response relationship and duration must be studied. More studies are needed in the context of the safety of the chronic use of celery as a daily routine for hypertensive patients.

5. Conclusion

Hypertension is increasing worldwide and contributes to different cardiovascular diseases. Targeted celery-based interventions can provide an opportunity to regulate high blood pressure to avoid progression to other complications. Similar results have been reported in scientific literature. Thus, celery can be considered an antihypertensive agent. However, a dose-response relationship should also be studied, as it is a major factor in disease prevention and treatment strategies.

Data Availability

The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

References

G. Y. Tang, X. Meng, Y. Li, C. N. Zhao, Q. Liu, and H. B. Li, “Effects of vegetables on cardiovascular diseases and related mechanisms,” Nutrients, vol. 9, no. 8, p. 857, 2017.
View at: Publisher Site | Google Scholar
T. Y. C. Tan, X. Y. Lim, N. A. Norahmad et al., “Neurological applications of celery (Apium graveolens): a scoping review,” Molecules, vol. 28, no. 15, p. 5824, 2023.
View at: Publisher Site | Google Scholar
World Health Organization, Hypertension [Internet], WHO press, Geneve, 2023, https://www.who.int/news-room/fact-sheets/detail/hypertension.
Y. Khader, A. Batieha, H. Jaddou et al., “Hypertension in Jordan: prevalence, awareness, control, and its associated factors,” International Journal of Hypertension, vol. 2019, Article ID 3210617, 8 pages, 2019.
View at: Publisher Site | Google Scholar
K. Keylani, F. A. Mojeni, A. Khalaji et al., “Endoplasmic reticulum as a target in cardiovascular diseases: is there a role for flavonoids?” Frontiers in Pharmacology, vol. 13, article 1027633, 2023.
View at: Publisher Site | Google Scholar
N. Hedayati, M. Bemani Naeini, A. Mohammadinejad, and S. A. Mohajeri, “Beneficial effects of celery (Apium graveolens) on metabolic syndrome: a review of the existing evidences,” Phytotherapy Research, vol. 33, no. 12, pp. 3040–3053, 2019.
View at: Publisher Site | Google Scholar
N. Fatima, S. Ashique, A. Upadhyay et al., “Current landscape of therapeutics for the management of hypertension-a review,” Current Drug Delivery, vol. 21, no. 5, pp. 662–682, 2024.
View at: Publisher Site | Google Scholar
R. L. Siantar, F. M. Simanjuntak, and T. R. Aritonang, “Efectiveness of celery (Apium graveolens) on hppertension in the elderly,” Science Midwifery, vol. 9, no. 2, pp. 360–365, 2021.
View at: Google Scholar
N. C. N. Azizah, D. Astuti, Z. Fanani, S. Karyati, and W. Kurnia, “The influence of celery juice againts blood pressure reduction in hypertension,” Journal of Physics: Conference Series, vol. 1477, no. 6, article 062009, 2020.
View at: Publisher Site | Google Scholar
A. R. Khairullah, T. I. Solikhah, A. N. M. Ansori et al., “Review on the pharmacological and health aspects of Apium graveolens or celery: an update,” Systematic Reviews in Pharmacy, vol. 12, no. 2, 2021.
View at: Google Scholar
R. Oktarina and S. Rahmawaty, “The use of celery (Apium graveolens L.) for reducing blood pressure in individual with hypertension in Indonesia: a review paper,” in 4th international conference current breakthrough in pharmacy (ICB-pharma 2022), pp. 261–268, Atlantis Press, 2022.
View at: Google Scholar
M. Shayani Rad, M. Moohebati, S. MohammadEbrahimi, V. S. Motamedshariaty, and S. A. Mohajeri, “Safety evaluation and biochemical efficacy of celery seed extract (Apium graveolens) capsules in hypertensive patients: a randomized, triple-blind, placebo-controlled, cross-over, clinical trial,” Inflammopharmacology, vol. 30, no. 5, pp. 1669–1684, 2022.
View at: Publisher Site | Google Scholar
J. D. Illes, “Blood pressure change after celery juice ingestion in a hypertensive elderly male,” Journal of Chiropractic Medicine, vol. 20, no. 2, pp. 90–94, 2021.
View at: Publisher Site | Google Scholar
Y. Tang and A. Chen, “Curcumin prevents leptin raising glucose levels in hepatic stellate cells by blocking translocation of glucose transporter-4 and increasing glucokinase,” British Journal of Pharmacology, vol. 161, no. 5, pp. 1137–1149, 2010.
View at: Publisher Site | Google Scholar
F. Tashakori-Sabzevar, B. M. Razavi, M. Imenshahidi et al., “Evaluation of mechanism for antihypertensive and vasorelaxant effects of hexanic and hydroalcoholic extracts of celery seed in normotensive and hypertensive rats,” Revista Brasileira de Farmacognosia, vol. 26, no. 5, pp. 619–626, 2016.
View at: Publisher Site | Google Scholar
M. H. Moghadam, M. Imenshahidi, and S. A. Mohajeri, “Antihypertensive effect of celery seed on rat blood pressure in chronic administration,” Journal of Medicinal Food, vol. 16, no. 6, pp. 558–563, 2013.
View at: Publisher Site | Google Scholar
M. Dianat, A. Veisi, A. Ahangarpour, and H. F. Moghaddam, “The effect of hydro-alcoholic celery (Apiumgraveolens) leaf extract on cardiovascular parameters and lipid profile in animal model of hypertension induced by fructose,” Avicenna Journal of Phytomedicine, vol. 5, no. 3, pp. 203–209, 2015.
View at: Google Scholar
R. Rosa and H. Rivai, “Phytochemical and antihypertensive tests of celery (Apium graveolens L.) and garlic (Allium sativum L.) formula,” vol. 6, no. 7, pp. 40–49, 2021.
View at: Google Scholar
F. Sohrabi, S. Niazmand, M. Mahmoudabady, and M. J. Niazmand, “The vasodilatory effect of Apium graveolens L (celery) seed in isolated rat aorta: the roles of endothelium, calcium and potassium channels,” Avicenna Journal of Phytomedicine, vol. 11, no. 1, pp. 44–53, 2021.
View at: Google Scholar
K. Gautam, “Analyzing celery seed extract’s role in hypertension management: a clinical trial commentary,” Hypertension Journal, vol. 9, no. 1, pp. 23–25, 2023.
View at: Publisher Site | Google Scholar
A. Ahmad and S. Rahman, “Inhibitory effect of celery extract (Apium gravolens Linn) on blood pressure reduction in hypertension elderly in Iman Clinic,” Buletin Farmatera, vol. 7, no. 2, 2022.
View at: Google Scholar
M. Shayani Rad, M. Moohebati, and S. A. Mohajeri, “Effect of celery (Apium graveolens) seed extract on hypertension: a randomized, triple-blind, placebo-controlled, cross-over, clinical trial,” Phytotherapy Research, vol. 36, no. 7, pp. 2889–2907, 2022.
View at: Publisher Site | Google Scholar
M. U. Zafar, A. Rasheed, and H. Ismail, “Exploring the effects of celery stem on blood pressure, and associated parameters as social determinants in hypertensive individuals: a randomized control trail,” Annals of Human and Social Sciences, vol. 4, no. 4, pp. 118–126, 2023.
View at: Publisher Site | Google Scholar
A. E. Doyle, “Hypertension and vascular disease,” American Journal of Hypertension, vol. 4, no. 2_Part_2, pp. 103S–106S, 1991.
View at: Publisher Site | Google Scholar
H. Sui, Q. Yu, Y. Zhi, G. Geng, H. Liu, and H. Xu, “Effects of apigenin on the expression of angiotensin-converting enzyme 2 in kidney in spontaneously hypertensive rats,” Wei Sheng Yan Jiu = Journal of Hygiene Research, vol. 39, no. 6, p. 693, 2010.
View at: Google Scholar
P. J. C. Anjos, A. O. Lima, P. S. Cunha et al., “Cardiovascular effects induced by linalool in normotensive and hypertensive rats,” Zeitschrift für Naturforschung C, vol. 68, no. 5-6, pp. 181–190, 2013.
View at: Publisher Site | Google Scholar
J. Su, H.-T. Xu, J.-J. Yu et al., “Luteolin ameliorates hypertensive vascular remodeling through inhibiting the proliferation and migration of vascular smooth muscle cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 364876, 14 pages, 2015.
View at: Publisher Site | Google Scholar
J. Zhu, Y. Zhang, and C. Yang, “Protective effect of 3-n-butylphthalide against hypertensive nephropathy in spontaneously hypertensive rats,” Molecular Medicine Reports, vol. 11, no. 2, pp. 1448–1454, 2015.
View at: Publisher Site | Google Scholar
D. Tsi, N. P. Das, and B. K. Tan, “Effects of aqueous celery (Apium graveolens) extract on lipid parameters of rats fed a high fat diet,” Planta Medica, vol. 61, no. 1, pp. 18–21, 1995.
View at: Publisher Site | Google Scholar
F.-N. Ko, T.-F. Huang, and C.-M. Teng, “Vasodilatory action mechanisms of apigenin isolated from Apium graveolens in rat thoracic aorta,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1115, no. 1, pp. 69–74, 1991.
View at: Publisher Site | Google Scholar
V.-G. Jorge, J.-R. L. Ángel, T.-S. Adrián et al., “Vasorelaxant activity of extracts obtained from Apium graveolens: possible source for vasorelaxant molecules isolation with potential antihypertensive effect,” Asian Pacific Journal of Tropical Biomedicine, vol. 3, no. 10, pp. 776–779, 2013.
View at: Publisher Site | Google Scholar
J. V. A. Santiago, J. Jayachitra, M. Shenbagam, and N. Nalini, “-Limonene attenuates blood pressure and improves the lipid and antioxidant status in high fat diet and L-NAME treated rats,” Journal of Pharmaceutical Sciences and Research, vol. 2, no. 11, pp. 752–758, 2010.
View at: Google Scholar
F. F. Tang, J. X. Guo, J. Zhang, J. Li, and M. Su, “Study on hypotensive and vasodilatory effects of celery juice,” Food Science, vol. 28, no. 1, pp. 322–325, 2007.
View at: Google Scholar
L. M. Chai, L. Tian, Y. Li, C. S. Liu, and L. Y. Wu, “Antihypertensive effects of roots of Apium graveolens extract in renal hypertensive rats,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 16, no. 11, pp. 101–103, 2010.
View at: Google Scholar
T. Verma, M. Sinha, N. Bansal, S. R. Yadav, K. Shah, and N. S. Chauhan, “Plants used as antihypertensive,” Natural Products and Bioprospecting, vol. 11, no. 2, pp. 155–184.
View at: Publisher Site | Google Scholar
S. Branković, D. Kitić, M. Radenković et al., “Hypotensive and cardioinhibotory effects of the aqueous and ethanol extracts of celery (Apium graveolens, Apiaceae),” Acta Medica Medianae, vol. 49, no. 1, pp. 13–16, 2010.
View at: Google Scholar
Z. Ma, M. Zheng, Z. Liu et al., “Identification of potential angiotensin-I-converting enzyme inhibitory components in celery seed using UHPLC-MS and molecular docking,” Process Biochemistry, vol. 128, pp. 98–105, 2023.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2024 Sondos Alobaidi and Eman Saleh. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

347

Downloads

180

Citations